Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hereditary prion protein amyloidoses.

Bernardino Ghetti1, Fabrizio Tagliavini, M Takao

  • 1Department of Pathology and Laboratory Medicine and Indiana Alzheimer Disease Center, Indiana University School of Medicine, 635 Barnhill Drive, MS A128, Indianapolis, IN 46202-5120, USA. bghetti@iupui.edu

Clinics in Laboratory Medicine
|May 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-nucleus transcriptomics identifies a shared vulnerable excitatory neuronal population across typical and atypical Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same author

A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions.

Nature genetics·2026
Same author

Classification of tauopathies from human brain homogenates through salt-modulated tau amplification.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Pathological TDP-43 filaments accumulate at synapses and cause synaptic dysfunction.

bioRxiv : the preprint server for biology·2026
Same author

Distinct TAF15 amyloid filament folds define multiple subtypes of FTLD-TAF15.

bioRxiv : the preprint server for biology·2026
Same author

Alzheimer's disease polygenic risk in early- and late-onset Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Prion protein (PrP) amyloid accumulation defines inherited prion diseases like Gerstmann-Sträussler-Scheinker disease (GSS) and PrP cerebral amyloid angiopathy (PrP-CAA). Different PrP isoforms are found in GSS brains.

Area of Science:

  • Neuroscience
  • Pathology
  • Biochemistry

Background:

  • Prion protein (PrP) amyloid accumulation is a key feature of certain inherited prion diseases.
  • Gerstmann-Sträussler-Scheinker disease (GSS) and PrP cerebral amyloid angiopathy (PrP-CAA) are characterized by PrP amyloidosis.
  • These conditions can present with co-occurring pathologies like spongiform degeneration or neurofibrillary tangles.

Purpose of the Study:

  • To detail the pathological hallmarks of inherited prion diseases.
  • To describe the specific types of PrP amyloidosis and associated pathologies in GSS and PrP-CAA.
  • To identify the PrP isoforms present in GSS.

Main Methods:

  • Pathological examination of brain tissue from patients with GSS and PrP-CAA.
  • Immunohistochemical analysis to identify amyloid deposits and other pathological markers.

Related Experiment Videos

  • Biochemical analysis to characterize PrP isoforms, including proteinase K resistance.

    • Main Results:

    • PrP amyloid accumulation is confirmed as the hallmark of GSS and PrP-CAA.
    • In GSS, parenchymal amyloidosis can occur alongside spongiform degeneration or neurofibrillary tangles.
    • In PrP-CAA, vascular amyloidosis is observed with neurofibrillary tangles.
    • N-truncated and C-truncated proteinase K-resistant PrP isoforms were identified in GSS brains.

    Conclusions:

    • The study elucidates the distinct pathological presentations of GSS and PrP-CAA.
    • Identification of specific PrP isoforms in GSS contributes to understanding disease mechanisms.
    • This research highlights the heterogeneity of prion protein aggregation in inherited prion diseases.